Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Novartis profits down in first quarter

Share this article

13:55 CEST+02:00

Swiss pharmaceutical giant Novartis saw its first quarter net profit fall 4.0 percent to $2.82 billion, the company announced on Tuesday.

 

Swiss pharmaceutical giant Novartis saw its first quarter net profit fall 4.0 percent to $2.82 billion, the company announced on Tuesday.

The fall was mainly due to financing costs related to its purchase of eyecare giant Alcon, the company said.

One-off costs associated with merging Alcon over the next three years are expected to reach $600 million. The sum includes severance, retention and relocation charges, said the group.

The integration of Alcon into Novartis' IT platform alone is estimated to cost around $350 million, it added in its earnings statement.

Meanwhile, sales were up 16 percent in the first three months of the year at $14 billion, as the group benefitted from reporting in the US dollar, which has weakened against most key currencies.

The currency impact translated to a 2.0 percent boost on sales, noted the group.

Novartis chief executive Joseph Jimenez expressed satisfaction at the results, saying that "contributions from all businesses led to a good start in 2011."

The Basel-based group confirmed its targets for the year, saying that it expects sales to "grow around the double-digit mark in 2011."

It added that if exchange rates in March were to prevail for the whole year, there would be a positive impact of 3.0 percent on sales, and a negative impact of -2.0 percent on its operating income for the full year.

 

Get notified about breaking news on The Local

Share this article

Advertisement

From our sponsors

Learn French in Switzerland: A fully immersive experience

Hiking in the Swiss Alps, visiting local chocolate factories, wine-tastings, jazz festivals and car shows are not part of your typical language course. Unless, that is, it's an Alpadia language course.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement